Development of Fulminant Type 1 Diabetes Mellitus in the Course of Treatment with Atezolizumab for Hepatocellular CarcinomaMunehiro Ikeda, Naoki Kanda, Risa Takebayashi et al.|Internal Medicine|2022Cited by 4